JCNAX
Price
$26.36
Change
+$0.29 (+1.11%)
Updated
Apr 22, 6:59 PM EST
VEXAX
Price
$123.98
Change
+$1.24 (+1.01%)
Updated
Apr 22, 6:59 PM EST
Ad is loading...

Analysis and predictions JCNAX vs VEXAX

Header iconJCNAX vs VEXAX Comparison
Open Charts JCNAX vs VEXAXBanner chart's image
Janus Henderson Contrarian A
Price$26.36
Change+$0.29 (+1.11%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Admiral
Price$123.98
Change+$1.24 (+1.01%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JCNAX vs VEXAX Comparison Chart

Loading...

VS
JCNAX vs. VEXAX commentary
Apr 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCNAX is a StrongSell and VEXAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 104B vs. JCNAX (4.83B). VEXAX pays higher dividends than JCNAX: VEXAX (1.20) vs JCNAX (0.27). JCNAX was incepted earlier than VEXAX: JCNAX (15 years) vs VEXAX (23 years). JCNAX is a more actively managed with annual turnover of: 45.00 vs. VEXAX (11.00). JCNAX has a lower initial minimum investment than VEXAX: JCNAX (2500) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 18.37 vs. JCNAX (7.22). VEXAX return over 5 years is better than : 39.28 vs. JCNAX (29.63).
JCNAXVEXAXJCNAX / VEXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years23 years-
Gain YTD2.131-0.476-447%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets4.83B104B5%
Annual Yield % from dividends0.271.2023%
Returns for 1 year7.2218.3739%
Returns for 3 years-11.49-11.01104%
Returns for 5 years29.6339.2875%
Returns for 10 years26.56108.3925%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX40.400.93
+2.36%
Baxter International
WRLD135.712.34
+1.75%
World Acceptance Corp
CRNX43.440.47
+1.09%
Crinetics Pharmaceuticals
ALPP0.75N/A
-0.13%
Alpine 4 Holdings
GTHX4.10-0.01
-0.24%
G1 Therapeutics